STOCK TITAN

Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Establishment Labs Holdings Inc. (NASDAQ: ESTA) has announced participation in the UBS Genomics 2.0 and MedTech Innovations Summit from August 10-12, 2021. CEO Juan José Chacón-Quirós and Interim CFO Raj Denhoy will address attendees on August 12 at 8:00 am ET. A live webcast of their presentation will be available on the company's investor relations website, along with an archived version post-event. Establishment Labs specializes in women's health, notably breast aesthetics and reconstruction, marketing over 1.6 million Motiva Implants® worldwide since 2010.

Positive
  • Participation in UBS Genomics Summit enhances corporate visibility.
  • Presentation by CEO and CFO indicates leadership engagement with investors.
  • Established product portfolio with over 1.6 million Motiva Implants® sold globally.
Negative
  • None.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 2021.

A live webcast of the presentation will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcast will be available on the same website following the completion of the event.

About Establishment Labs

Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness. The company’s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants® that include a number of innovative and patented features designed to deliver improved aesthetic and clinical outcomes. Since commercial launch in 2010, more than 1.6 million Motiva Implants® have been delivered to plastic surgeons in over 80 countries. The company also offers or has under development a number of related products and technologies, including the Motiva Flora® tissue expander and Motiva MIA®, the company’s minimally invasive breast enhancement procedure. In 2018, Establishment Labs received an investigational device exemption (IDE) from the FDA for the Motiva Implant® and began a clinical trial to support regulatory approval in the United States. Motiva Implants® are manufactured at the company’s two facilities in Costa Rica, which are compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. Please visit our website for additional information at www.establishmentlabs.com.

FAQ

When will ESTA participate in the UBS Genomics 2.0 and MedTech Innovations Summit?

Establishment Labs will participate from August 10-12, 2021, with presentations scheduled on August 12 at 8:00 am ET.

Who will present for ESTA at the UBS Summit?

CEO Juan José Chacón-Quirós and Interim CFO Raj Denhoy will present.

How can I watch ESTA's presentation at the UBS Summit?

The presentation will be available via a live webcast on the Establishment Labs investor relations website.

What is the focus of Establishment Labs?

Establishment Labs specializes in improving women’s health, particularly in breast aesthetics and reconstruction.

Establishment Labs Holdings Inc.

NASDAQ:ESTA

ESTA Rankings

ESTA Latest News

ESTA Stock Data

1.16B
25.28M
11.28%
98.89%
17.16%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
ALAJUELA